AKT1 and T-cell large granular lymphocyte leukemia: Similarly, PDGF functions as another central contributor to LGL leukemia pathogenesis, with increased circulating PDGF levels in LGL leukemia patients, as well as activated PDGF downstream targets, such as PI3K and AKT/ERK [54,62].